<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03405727</url>
  </required_header>
  <id_info>
    <org_study_id>CHUB-diet</org_study_id>
    <nct_id>NCT03405727</nct_id>
  </id_info>
  <brief_title>Improvement of Sarcopenia in Patients Following Two Different Diets</brief_title>
  <official_title>Improvement of Sarcopenia in Sarcopenia Patients Following Two Different Diets</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brugmann University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brugmann University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sarcopenia is defined as a decrease in muscular strength and muscle mass, accompanied by a&#xD;
      decrease in physical performance. Seniors might develop sarcopenia because of a decreased&#xD;
      physical activity and a decreased protein intake. Many patients also develop sarcopenia after&#xD;
      a long stay in an intensive care unit.&#xD;
&#xD;
      Protein intake is very important when treating sarcopenia. However, meeting the protein&#xD;
      requirements at home proves difficult. Oral dietary supplements, given in addition to the&#xD;
      other known recommendations, might provide a solution.&#xD;
&#xD;
      This study will assess the efficacy of the oral dietary supplements for the treatment of&#xD;
      sarcopenia.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Lack of human ressources&#xD;
  </why_stopped>
  <start_date type="Actual">March 20, 2018</start_date>
  <completion_date type="Actual">September 11, 2018</completion_date>
  <primary_completion_date type="Actual">September 11, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prehension force</measure>
    <time_frame>3 months after first consultation</time_frame>
    <description>Prehension force, as measured by a dynamometer on the dominant hand</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prehension force</measure>
    <time_frame>6 months after first consultation</time_frame>
    <description>Prehension force, as measured by a dynamometer on the dominant hand</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fat mass evaluation</measure>
    <time_frame>3 months after first consultation</time_frame>
    <description>Measured by a Harpaden compass on the tricipital skin fold</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fat mass evaluation</measure>
    <time_frame>6 months after first consultation</time_frame>
    <description>Measured by a Harpaden compass on the tricipital skin fold</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle mass evaluation</measure>
    <time_frame>3 months after first consultation</time_frame>
    <description>Brachial muscular circumference (measured by tape)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle mass evaluation</measure>
    <time_frame>6 months after first consultation</time_frame>
    <description>Brachial muscular circumference (measured by tape)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Walking speed</measure>
    <time_frame>3 months after first consultation</time_frame>
    <description>Walking speed on a 4 meters distance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Walking speed</measure>
    <time_frame>6 months after first consultation</time_frame>
    <description>Walking speed on a 4 meters distance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>&quot;Time Up and Go&quot; test</measure>
    <time_frame>3 months after first consultation</time_frame>
    <description>Mobility assessment of the patient</description>
  </primary_outcome>
  <primary_outcome>
    <measure>&quot;Time Up and Go&quot; test</measure>
    <time_frame>6 months after first consultation</time_frame>
    <description>Mobility assessment of the patient</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sedentary lifestyle questionnaire</measure>
    <time_frame>3 months after first consultation</time_frame>
    <description>Evaluation of the physical activity by means of a questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sedentary lifestyle questionnaire</measure>
    <time_frame>6 months after first consultation</time_frame>
    <description>Evaluation of the physical activity by means of a questionnaire</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>Standard treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral dietary supplements</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Oral dietary supplements</intervention_name>
    <description>Protein enriched diet</description>
    <arm_group_label>Oral dietary supplements</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients hospitalized within the CHU Brugmann, Brussels&#xD;
&#xD;
          -  Patients diagnosed with sarcopenia (by means of a dynamometer)&#xD;
&#xD;
          -  Patients having stayed in an intensive care unit for longer than 5 weeks&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Oncology patients&#xD;
&#xD;
          -  Anorexic patients&#xD;
&#xD;
          -  Patients having a life expectancy of less than 6 months&#xD;
&#xD;
          -  Demented patients&#xD;
&#xD;
          -  BPCO patients&#xD;
&#xD;
          -  Patients with neuropathies&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Turkan Dalgic</last_name>
    <role>Principal Investigator</role>
    <affiliation>Haute Ecole Lucia De Brouck√®re</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Brugmann</name>
      <address>
        <city>Brussels</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>January 15, 2018</study_first_submitted>
  <study_first_submitted_qc>January 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2018</study_first_posted>
  <last_update_submitted>August 5, 2020</last_update_submitted>
  <last_update_submitted_qc>August 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brugmann University Hospital</investigator_affiliation>
    <investigator_full_name>Tatiana Besse-Hammer</investigator_full_name>
    <investigator_title>Head of clinic</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

